Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hydroxychloroquine in Primary Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers at Risk of Exposure: Randomised Control Trial

NCT04370015 is registered in ClinicalTrials.gov with Services Institute of Medical Sciences, Pakistan as lead sponsor.

NCT NCT04370015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04370015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hydroxychloroquine in Primary Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers at Risk of Exposure: Randomised Control Trial
Lead sponsor
Services Institute of Medical Sciences, Pakistan
Phase
Not applicable
Overall status
Unknown status
Start date
May 15, 2020
Completion date
October 15, 2020
Enrollment
374 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthcare workers, sars-cov-2